Business Description

Description
Alzex Neuropharma Inc is a development-stage biopharmaceutical company that has developed and patented precision therapeutics for the treatment of Alzheimer's Disease and other neurological diseases. The company currently holds two families of patents via an exclusive and unlimited licensing agreement with INSA (Institut National des Sciences Appliquees) a French academic engineering and research institute.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 21.4
9-Day RSI 29.94
14-Day RSI 34.79
6-1 Month Momentum % -25
12-1 Month Momentum % -25

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History

Financials

TRRI's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:TRRI

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Alzex Neuropharma Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) 0
Beta -62.67
Volatility % 424.75
14-Day RSI 34.79
14-Day ATR ($) 0.008346
20-Day SMA ($) 0.1394
12-1 Month Momentum % -25
52-Week Range ($) 0.1 - 0.5
Shares Outstanding (Mil) 1.51

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Alzex Neuropharma Inc Filings

Filing Date Document Date Form
No Filing Data

Alzex Neuropharma Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Alzex Neuropharma Inc Frequently Asked Questions

What is Alzex Neuropharma Inc(TRRI)'s stock price today?
The current price of TRRI is $0.10. The 52 week high of TRRI is $0.50 and 52 week low is $0.10.
When is next earnings date of Alzex Neuropharma Inc(TRRI)?
The next earnings date of Alzex Neuropharma Inc(TRRI) is .
Does Alzex Neuropharma Inc(TRRI) pay dividends? If so, how much?
Alzex Neuropharma Inc(TRRI) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1